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ABSTRACT 
 
JOSHUA MICHAEL URONIS:  Histological and Molecular Analysis of Colorectal Cancer 
Morphology 
(Under the direction of Dr. David W. Threadgill) 
  
 
 
Increasing awareness of the prevalence of colorectal cancer (CRC) has resulted in a 
large effort to establish more informative animal-based models to elucidate the nature of this 
disease.  One of the most widely used approaches utilizes the laboratory mouse in a variety 
of genetic and chemical-based models to study both inherited and sporadic (non-inherited) 
colorectal cancers.  Colorectal cancers are classified into two morphological categories, 
polypoid or flat.  Growing evidence suggests that flat CRCs account for 10-20% of all CRCs 
and that these lesions are more difficult to detect and are frequently associated with more 
advanced pathologies.  We report using the azoxymethane (AOM) model for human CRC in 
combination with serial colonoscopic and histologic analyses that flat CRCs arise through a 
flat adenomatous intermediate rather than de novo as previously suggested.  Like polypoid 
tumors, all flat tumors show a significant increase in nuclear beta-catenin (CATNNB1) 
supported by similar frequencies of mutations in the phosphorylation domain-coding region 
of Catnnb1.  However in contrast to previous reports, tumors bearing higher “oncogenic 
potential” do not cluster in codon 41 of Catnnb1.  Additionally, there are no differences in 
the frequency of mutations in codons 12 and 13 of Kras or codon 624 of Braf.  Upon 
performing whole genome mouse microarray analyses, we found no significant differences in 
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gene expression between flat and polypoid adenomas, however we did observe significant 
and mutually exclusive changes in gene expression between flat and polypoid adenomas 
compared to the normal colon.  Based on these findings we hypothesize that the 
mechanism(s) which control formation of flat versus polypoid cancers lies within the normal 
colon and is strongly influenced by genetic background.  We present here a list of candidate 
genes, which are differentially expressed between flat and polypoid tumors compared to the 
normal colon that may function in the determination of tumor morphology.  Our work may 
provide insight into the mechanism(s) by which these distinct CRC morphologies develop 
and may serve as a foundation on which to identify novel genetic markers that will allow for 
the identification of individuals at increased risk for developing flat CRC.
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2 
Abstract 
 
 
Colorectal cancer is one of the most prevalent cancers of humans. To experimentally 
investigate this common disease, numerous murine-based models have been established. 
These models accurately recapitulate the molecular and pathological characteristics of human 
colorectal cancer. This review focuses on the variety of murine models of human colorectal 
cancer that are available to the research community and on their use to identify common and 
distinct characteristics of colorectal cancer.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
Introduction 
 
Colorectal cancer (CRC) is expected to account for approximately 153,000 new cases and 
52,000 deaths in the United States in 2007 (American Cancer Society).  While some forms of 
CRC are familial, a majority of cases are considered to be non-familial or sporadic in their 
occurrence.  Many genetic and carcinogen-based murine models have been developed that 
recapitulate human CRC through alteration of a variety of signaling pathways (Table 1.1). 
The most commonly used models perturb of the WNT/CTNNB1 (wingless-related MMTV 
integration site/beta-catenin) signaling pathway, which is involved in the majority of human 
CRCs.  Although CRCs are heterogeneous, similarities across CRCs with different etiologies 
and between species are becoming apparent. A recent comparison of WNT and non-WNT 
mediated murine models implicated MYC as a key mediator of CRC, thereby linking 
seemingly independent pathways (Hanada et al. 2006; Kaiser et al. 2007; Rigby et al. 2007; 
Sansom et al. 2007). A similar role for MYC during human CRC development is also 
suggested from its widespread up-regulation in human CRCs. Although murine models have 
been established that model the early stages of CRC, less progress has been achieved in 
establishing models that accurately recapitulate the later stages of invasion and metastasis.  
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WNT pathway-mediated models of CRC   
APC models 
The ApcMin (multiple intestinal neoplasia allele of the adenomatous polyposis coli gene) 
mouse model of human familial adenomatous polyposis (FAP) is the most widely used CRC 
model for studying tumor initiation and early progression.  The ApcMin model, originally 
induced and fortuitously identified in a mutagenesis program (Moser et al. 1990; Su et al. 
1992), bears one functional copy of the tumor suppressor Apc gene. Upon loss of the 
remaining wildtype copy of Apc, CTNNB1 is stabilized and transported to the nucleus where 
it functions as a transcriptional co-activator with the LEF/TCF family of transcription factors 
to stimulate cell cycle progression (Morin et al. 1997).  This loss of growth control results in 
the development of tens-to-hundreds of polyps in the small intestine and a small number of 
polyps in the colon, while a similar mutation in humans results in predominantly colonic 
polyps (Groden et al. 1991).   
Since discovery of the ApcMin allele, other mutant alleles have been described.  Gene 
targeting was used to generate ApcΔ716 and Apc1638 alleles that display polyp distributions 
similar to the ApcMin mouse (Fodde et al. 1994; Oshima et al. 1995).  However, the Apc1638 
model develops significantly fewer polyps than ApcMin, while the ApcΔ716 model develops 
more. Liver metastasis has been reported using the APC1638 model, possibly due to the 
notably longer lifespan of these mice compared to other Apc-mediated models. 
The observation that CRC predisposition in ApcMin mice is strain dependent led to the 
discovery of genetic loci called ‘Modifiers of Min’ (Mom) that modulate CRC susceptibility 
(Kwong et al. 2007).  While the genes underlying most Mom loci have not been identified, 
other modifiers of ApcMin-mediated CRC have been identified using crosses with mice 
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carrying mutations in specific genes.  Haploinsufficiency of the Krüppel-like factor 4 (Klf4) 
transcription factor or reduction in EGFR activity using the Egfrwa2 hypomorphic allele 
combined with loss of Apc enhances and suppresses, respectively, multiplicity in the small 
intestine and colon while showing no role in subsequent tumor progression (Ghaleb et al. 
2007).  In contrast, ApcMin mice that undergo loss of either the Pten tumor suppressor gene or 
the Ephb2 gene coding for a guidance receptor show enhanced tumor progression (Batlle et 
al. 2005; Shao et al. 2007). Loss of Ephb2 in mice coincides with a shift from small intestinal 
adenomas to advanced colon carcinomas, potentially providing clues to the disparity in tumor 
distribution between humans with FAP and mice carrying ApcMin (Batlle et al. 2005).  
Although Apc mutant mice have been invaluable in modeling human CRC, there 
remain several aspects of the human disease that are not recapitulated well with these 
models. Rodent endoscopy is not well suited for Apc mutant mice since they develop tumors 
predominantly in the small intestine; endosocpy is more appropriate for models that develop 
colorectal lesions.  Additionally, Apc mutant mice rarely develop metastases to distant 
organs, which is the most clinical important aspect of human CRC.   
The generation of gene-specific mutations in rats by N-ethyl-N-nitrosourea (ENU) 
mutagenesis provides a new avenue for modeling human CRC (Zan et al. 2003).  Recently, 
the Pirc (polyposis in rat colon) rat model of human CRC was generated that has a mutation 
in Apc (Amos-Landgraf et al. 2007). Unlike the ApcMin mouse model where the incidence of 
colon tumors is low, the Pirc model develops colon tumors with 100% incidence by four 
months of age.  The Pirc model opens opportunities to perform experimental studies that are 
difficult in mice.  Apc mutant mice can develop invasive cancer but typically have shortened 
life spans due to intestinal blockage (Boivin et al. 2003). Conversely, rats are less susceptible 
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to intestinal blockage by tumors because of their larger intestinal diameters.  In mice of at 
least six months of age, twenty percent of tumors in the Pirc model become invasive (Boivin 
et al. 2003; Amos-Landgraf et al. 2007). Although no distant metastases have been reported 
in the initial analysis of the Pirc model, metastasis of CRCs to the liver have been reported in 
the rat (Nordlinger et al. 1991). 
 
Mismatch repair (MMR) deficient models 
Hereditary non-polypoisis colon cancer (HNPCC) is an inherited condition in which 
inactivation of one of several DNA mis-match repair (MMR) genes, like MLH1, MSH2, 
MSH6, and PMS2, result in defective DNA repair (Lynch and de la Chapelle 2003).  In 
humans this leads to the development of a variety of cancers including that of the colon, 
endometrium, ovary, and stomach (Lynch and de la Chapelle 2003).  A number of mutant 
mouse lines have been generated to model the loss of function of MMR genes in humans.  
Mice deficient for Mhl1, Msh2 and Msh6 develop cancers of the stomach, small intestine and 
colon.  However, due to the inherent nature of defective MMR machinery, these mice also 
develop cancers of the lymphatic system, skin, cervix and lung (Reitmair et al. 1996; 
Edelmann et al. 1997; Edelmann et al. 1999; Edelmann et al. 2000).   
Analysis of MMR deficient mice carrying one functional copy of Apc showed that 
loss of normal MMR results in a high percentage of Apc-inactivating mutations and an 
elevated frequency of tumor development (Reitmair et al. 1996; Kuraguchi et al. 2001).  
Mice deficient for Mlh1 and heterozygous for the Apc1638N allele have a 40-fold increase in 
stomach and colon tumors compared to Apc1638N mice alone (Edelmann et al. 1999).  
Similarly, ApcMin mice lacking Msh2 have accelerated development of tumors, with increased 
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colon adenoma number and size suggesting roles for MSH2 in both tumor initiation and 
progression. Although loss of Msh3 does not lead to increased cancer predisposition until late 
in life, loss of Msh3 and Msh6 together results in an increase in gastrointestinal tumors at a 
much younger age, similar to mice deficient for either Mlh1 or Msh2 (Edelmann et al. 2000).   
 
Carcinogen-induced models 
While genetic models have proven useful in the investigation of cancer mechanisms, 
particularly for familial cancers such as FAP or HNPCC, most human CRCs are non-familial 
and occur sporadically. The colon-specific carcinogen azoxymethane (AOM), a down-stream 
metabolite of dimethylhyrdrazine (DMH), has proven useful in the investigation of the 
molecular mechanisms underlying the development of non-familial CRCs (Druckrey et al. 
1967).  Mice exposed to DMH or AOM develop colorectal tumors that accurately 
recapitulate pathologies seen in human CRC (Papanikolaou et al. 1998). Consistent with the 
ApcMin model, AOM-induced tumors result from activation of the WNT/CTNNB1 pathway. 
Unlike in Apc-mediated models, AOM-induced tumors are primarily caused by mutations in 
Ctnnb1, which results in ubiquitination-resistant CTNNB1 and development of colorectal 
adenomas with increased expression of the key cell cycle regulators Ccnd1 (cyclin D1) and 
Myc (Wang et al. 1998).   
Several modifier genes with relevance to humans including Ptprj (a receptor-type 
protein tyrosine phosphatase) have been identified using carcinogen-induced models of 
human CRC (Ruivenkamp et al. 2002).  Additionally, Pref1, up-regulated in response to 
AOM in the distal colon of tumor susceptible A/J but not resistant AKR/J mice, was 
identified using the AOM carcinogen model (Dong et al. 2004).  A direct link to 
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WNT/CTNNB1 signaling was suggested through a putative CTNNB1/TCF response element 
identified in the promoter of Pref1. 
More recently, the AOM model was used to investigate the etiology of CRCs with 
distinct morphologies.  CRCs with flat morphologies more frequently escape detection 
during routine colonoscopies than their larger polypoid counterparts, and with this realization 
have become increasingly apparent in recent years (Owen 1996; Saitoh et al. 2001; Soetikno 
et al. 2006; Speake et al. 2007).  The AOM model was used to show that flat and polypoid 
tumors arise independently, despite having a similar mutational spectrum (Uronis et al. 
2007).  
 
Non-WNT pathway-mediated models of CRC 
TGFB models 
The transforming growth factor beta (TGFB) signaling pathway functions in a variety 
of cellular processes including differentiation, growth suppression, deposition of extracellular 
matrix and apoptosis. Upon activation of TGFB receptors (TGFBR1, 2 and 3), intracellular 
SMAD2 and SMAD3 become phosphorylated, bind to SMAD4 and translocate to the 
nucleus where the complex interacts with other transcription factors to mediate down stream 
targets of TGFB (Blobe et al. 2000). In the normal colonic epithelium and in early stages of 
tumorigenesis, TGFB functions as a tumor suppressor by inhibiting the cell cycle through up-
regulation of Cdnk1a and Cdnk2b coding for cyclin-dependent protein kinase inhibitors 
(Derynck et al. 2001). CRCs often acquire resistance to TGFB signaling and at later stages of 
cancer progression, express increased levels of TGFB, promoting invasion and metastasis 
(Blobe et al. 2000).   
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Several TGFB pathway-associated models have been used to dissect the complex role 
of this pathway during CRC development.  Tgfb1 deficient mice die around three weeks of 
age due to extensive inflammation (Shull et al. 1992; Kulkarni et al. 1993). However, on a 
Rag2 deficient background, lacking functional B and T-cells, Tgfb1 deficient mice survive 
until adulthood (Diebold et al. 1995; Engle et al. 1999).  Mice deficient for both Tgfb1 and 
Rag2 rapidly develop carcinoma of the cecum and colon suggesting that inflammation in 
combination with loss of TGFB1 results in predisposition to cancer (Engle et al. 1999).  
Interestingly, CRCs do not form with Tgfb1 deficiency unless specific bacterial pathogens 
are present to induce inflammation (Maggio-Price et al. 2006).  Mutations in Smad2 and 
Smad4 have been reported to occur in human CRCs, but not in Smad3 (Eppert et al. 1996; 
Takagi et al. 1996; Thiagalingam et al. 1996).  Smad2 and Smad4 deficient mice are 
embryonic lethal, while Smad3 deficient mice are viable and develop highly invasive CRC, 
which metastasizes to lymph nodes by four-to-six months of age (Zhu et al. 1998).  Apc is 
not lost in TGFB-mediated tumors, nor do they display nuclear localization of CTNNB1 
suggesting the existence of non-WNT/CTNNB1-mediated mechanism for tumor initiation 
(Kaiser et al. 2007).  Consistent with current models of CRC and with the growth suppressive 
role of TGFB, mice deficient for Smad3 or heterozygous for a Smad4 mutant allele combined 
with mutant Apc develop an increased incidence of invasive carcinoma of the distal colon 
(Takaku et al. 1998; Sodir et al. 2006).  
 
Inflammation-mediated models  
The inflammatory diseases ulcerative colitis (UC) and Crohn’s Disease, collectively 
termed inflammatory bowel disease (IBD), result in chronic inflammation of the colon and 
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predisposition to the development of CRC (Itzkowitz and Harpaz 2004; Itzkowitz and Yio 
2004).  In mice the role of chronic inflammation in CRC was demonstrated by the discovery 
that prolonged administration of dextran sodium sulfate (DSS) results in chronic colitis and 
formation of high-grade dysplasia (Okayasu et al. 1990). A single dose of AOM followed by 
administration of DSS enhances tumor development and progression (Tanaka et al. 2003). 
The AOM/DSS model was used recently to show that deficiency for Sigirr (single 
immunoglobulin and toll-interleukin 1 receptor domain) increases susceptibility to CRC 
(Wald et al. 2003; Xiao et al. 2007).  Similar to Tgfb1 deficient mice, bacteria-induced 
inflammation is likely an important factor in SIGIRR-associated cancer.  
The AOM/DSS model has also been used to demonstrated the importance of the 
JAK/STAT (Janus kinase/signal transducers and activators of transcription) and NFKB 
(nuclear factor of kappa light chain gene enhancer in B-cells) pathways for inflammation-
mediated CRC (Wirtz and Neurath 2007).  Consistent with a role for the JAK/STAT 
pathway, loss of Socs1 and Socs3 (suppressors of cytokine signaling) expression results in 
increased activation of STAT1, STAT3 and NFKB and development of colorectal tumors 
(Hanada et al. 2006; Rigby et al. 2007).  A direct link between SOCS signaling and Myc 
exists since AOM/DSS-induced adenocarcinomas from Socs1 deficient mice have increased 
levels of nuclear CTNNB1 and Myc expression when compared to tumors from Socs1 
wildtype mice (Hanada et al. 2006).  Intestinal epithelium-specific deficiency for Socs3 does 
not result in chronic inflammation or development tumors.  However, when treated with 
AOM/DSS, these mice develop colon tumors preceded by inflammation suggesting that 
Socs3 expression in neighboring stroma may be required to suppress chronic inflammation 
and subsequently tumor promotion (Hanada et al. 2006; Rigby et al. 2007).  While colorectal 
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tumors from Socs3 deficient mice have not been shown to display high levels of nuclear 
CTNNB1 as is seen in tumors from Socs1 deficient mice, Socs3 deficiency has been shown 
to result in increased Myc expression in mammary tissue (Sutherland et al. 2006).  
 
MYC as a central mediator of CRC  
Recent evidence suggests that MYC functions as a global mediator of the oncogenic 
process, linking together a seemingly heterogeneous pool of molecular mechanisms 
underlying cancer development (Fig. 1.1) (Knoepfler 2007).  The recent discovery that 
deletion of Myc rescues Apc deficiency elucidated a potential role of MYC as a key mediator 
of WNT/CTNNB1-initiated CRC (Sansom et al. 2007).  Additionally, available evidence 
suggests that MYC is also involved in mediating non-WNT/CTNNB1-initiated colorectal 
cancers. Although WNT/CTNNB1 and non-WNT/CTNNB1-mediated CRCs can be 
discriminated by unique gene expression signatures, all tumors from both classes display 
increased Myc expression (Kaiser et al. 2007).  Myc is a direct transcriptional target of the 
WNT/CTNNB1 pathway, while TGFB signaling is associated with Myc repression through 
SMAD3 binding to a repressive SMAD binding element (RSBE) within the Myc promoter 
(Frederick et al. 2004).  
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Conclusions 
 
A variety of genetic and carcinogen-induced murine models have provided important 
reagents for investigating the complexity of human CRC.  While each model has provided 
unique insights into human CRC, it is becoming increasingly apparent that the interactions 
between seemingly independent pathways are important for elucidating similarities among 
otherwise heterogeneous cancers.  Numerous lines of evidence are converging on MYC as a 
central mediator of CRC, perhaps through its role in chromatin remodeling (Knoepfler et al. 
2006; Knoepfler 2007).  While the exact role of MYC in the development of CRC is not fully 
understood, it is clear that increased attention on the role of MYC during CRC development 
and progression warrants further study.  
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Figure 1.1  Schematic illustration of Wnt/β-catenin- and Non-Wnt/β-catenin-mediated 
signaling pathways and their influence on colorectal cancer initiation and progression. 
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Table 1.1 Murine Models of Human Colorectal Cancer. 
 Strain Tumor Type Location Multiplicity Reference 
WNT pathway      
Apc      
ApcMin C57BL/6J adenoma small intestine 0.5-30 7 
ApcMin BTBR/Pas adenoma small intestine 600 12 
Apc1638 C57BL/6J adenoma/carcinoma small intestine, colon 4 10 
Apc 716 C57BL/6J adenoma small intestine, colon 254 11 
Azoxymethane A/J adenoma/carcinoma distal colon 36.4 27 
Azoxymethane SWR/J adenoma/carcinoma distal colon 16.3 27 
Azoxymethane AKR/J adenoma/carcinoma distal colon 0.12 27 
ApcMin C57BL/6J adenoma small intestine 5.7 14 
ApcMin, Pten+/- C57BL/6J/129 adenoma/carcinoma small intestine 22 14 
ApcMin C57BL/6J adenoma small intestine 18 13 
Klf4-/+,  ApcMin C57BL/6J adenoma small intestine 29 13 
ApcMin C57BL/6J adenoma small intestine 39 15 
Ephb2 cy , ApcMin C57BL/6J carcinoma small intestine 13 15 
ApcMin C57BL/6J adenoma colon 1 15 
Ephb2 cy , ApcMin C57BL/6J carcinoma colon 11 15 
      
Mismatch repair      
Mlh1-/- C57BL/6J/129/Ola (mixed) adenoma, carcinoma stomach, small intestine, colon 1.1 22 
Mlh1-/-, Apc1638/N Ola adenoma, carcinoma stomach, colon 45.1 22 
Msh2-/- C57BL/6J/129/Ola (mixed) adenoma, carcinoma small intestine, colon 2.6 24 
Msh2-/-, ApcMin C57BL/6J/129/Ola (mixed) adenoma small intestine, colon 333 24 
Msh6-/- C57BL/6J/129/Sv/SJL/J (mixed) adenoma, carcinoma small intestine 0.6 21,23 
Msh3-/-, Msh6-/- C57BL/6J/129/Sv/SJL/J (mixed) adnoma, carcinoma small intestine, colon 2.75 25 
      
Non-WNT 
pathway      
Tgfb      
Tgfb1-/-, Rag2-/- 129S6 x CF1  adenoma/carcinoma cecum, colon NR 41 
Smad3-/- 129/Sv carcinoma colon 3.8 46 
      
Inflammation      
DSS CBA/J & BALB/C high grade dysplasia colon NR 51 
AOM/DSS CD-1 adenoma/carcinoma    distal colon 5.8 52 
      
Modifiers of 
inflammation      
Socs1-/- NR adenoma/carcinoma proximal colon  NR 4 
Socs3-/- C57BL/6J adenoma colon NR 3 
Sigirr-/- C57BL/6J x 129/SvJ adenoma/carcinoma distal colon 17 54 
      
NR, not reported      
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Abstract 
 
Growing evidence suggests that flat colorectal cancers (CRCs) account for 10-20% of 
all CRCs and that these are frequently associated with more advanced pathologies.  However, 
controversy exists as to the origin and progression of flat CRCs compared with the more 
common polypoid-type morphology.  We report using the azoxymethane (AOM) mouse 
model for human CRC that KK/HIJ and I/LNJ mice develop different frequencies of flat and 
polypoid tumors; 83% of colon tumors in I/LNJ mice are flat compared to only 19% in 
KK/HIJ mice, indicating a strong genetic predisposition to the development of specific CRC 
morphologies.  Like polypoid tumors, all flat tumors show a significant increase in the level 
of nuclear beta-catenin (CATNNB1), supported by similar frequencies of mutations in the 
phosphorylation domain-coding region (codons 32-41) of Catnnb1.  However, in contrast to 
previous reports, tumors bearing higher “oncogenic potential” do not cluster in codon 41 of 
Catnnb1.  There are no differences between flat and polypoid tumors in the frequency of 
mutations in codons 12 and 13 of Kras or codon 624 of Braf.  Similarly, there are no 
differences between tumor morphologies in their location along the proximal-to-distal 
colonic axis or in the relative quantity of intra-tumor stromal myofibrobasts as marked by 
expression of alpha-smooth muscle actin (ACTA2).  Using a combination of serial 
colonoscopic and histological analyses, we definitively show that flat CRCs do not develop 
de novo but progress through a flat adenomatous stage to invasive carcinoma without transit 
through an intermediary polypoid stage.  
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Introduction 
 
Colorectal Cancer (CRC) is the third most commonly diagnosed cancer in the United 
States and accounts for the second most common cause of cancer-related deaths with ~ 
145,290 new cases and 56,290 deaths annually (American Cancer Society, 2005).  While 
advances have been made in the treatment of CRC, the most effective means of lowering 
cancer incidence is through prevention and early detection (American Cancer Society, 2005).  
Although colonoscopy is currently the most accurate and widely used method for the 
detection and removal of colonic neoplasms, there is growing evidence that CRCs with flat 
morphologies are more difficult to detect and are missed at higher rates, which may 
contribute to the high incidence of advanced CRC associated with flat morphologies 
(Kuramoto and Oohara 1989; Church et al. 2004; Ross and Waxman 2006; Soetikno et al. 
2006).  
Flat colorectal cancers were first described nearly thirty years ago in Japan and until 
recently, have been considered less common in western countries (Kariya et al. 1977; Muto 
et al. 1985; Saitoh et al. 2001; Hurlstone et al. 2007).  However, recent studies have shown 
that flat adenomas may comprise as many as 22% of colorectal tumors in the United States 
(Saitoh et al. 2001).  The discrepancy in the perceived frequency of flat CRCs has also 
contributed to contradictory hypotheses about the origin and progression of flat CRCs.  
Supporters of the adenoma-carcinoma sequence posit that flat carcinomas originate through 
an adenoma intermediate, either by ulceration of a polyp or through formation of a flat 
adenoma (Rubio and Shetye 1994; Kashida and Kudo 2006).  Others have asserted that the 
identification of flat carcinomas with no observable adenoma component suggests that flat 
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carcinomas arise de novo without progressing through an adenomatous intermediate (Spjut et 
al. 1979; Crawford and Stromeyer 1983; Kuramoto and Oohara 1989).  
To resolve the molecular and morphological development of flat CRCs, we 
molecularly analyzed azoxymethane (AOM)-induced flat and polypoid tumors and 
performed serial endoscopy of AOM-induced tumors arising in I/LNJ and KK/HIJ mice, 
which predominantly develop flat and polypoid tumors, respectively.  Here we demonstrate 
that there is a genetic predisposition for CRC morphology and that flat carcinomas have 
polypoid-type mutational spectra and histological characteristics but originate as flat 
adenomas, which have a lateral growth pattern without progressing through a polypoid stage. 
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Materials and Methods 
 
Mice.  KK/HIJ and I/LNJ mice were obtained from The Jackson Laboratory.  Mice 
between two and four months of age were injected intra-peritoneally with 10 mg/kg body 
weight azoxymethane (AOM) (Sigma-Aldrich) once a week for four or six weeks as 
previously described (Bissahoyo et al, 2005) (Fig. 2.1).  Mice were housed in ventilated racks 
and provided 5010 chow (LabDiet) and water ad libitum in an Association for Assessment 
and Accreditation of Laboratory Animal Care (ALAAC)-approved animal facility.  I/LNJ 
mice were euthanized by CO2 asphyxiation 6.5 months after the first AOM injection.  Due to 
the development of large tumors causing intestinal obstruction, KK/HIJ mice were sacrificed 
approximately five months after the first AOM injection.  All experiments were approved by 
the UNC Institutional Animal Care and Use Committee. 
 
Necropsy and tumor histology.  Upon sacrifice, colons were removed from the 
cecum to the rectum, gently flushed with PBS, placed on filter paper and splayed 
longitudinally.  Tumors were counted and diameters measured in their maximum dimension.  
Swiss rolls were prepared by gently rolling the splayed colons from the rectum to the cecum, 
pinned with a 30-ga needle, fixed in 10% neutral buffered formalin (NBF) over-night and 
paraffin-embedded before cutting seven-micrometer sections.  For histological analysis, 
sections were stained with hematoxylin and eosin (H&E) and photographed.  Sections near 
the center of each tumor were photographed and analyzed for both cross-sectional area as 
well as net tumor height using Image J (NIH).  The height of cross-sectioned tumors (with 
tumor base present) was determined by measuring perpendicularly from the muscularis 
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propria to the lumen surface.  Quantitative measurements were used to define the 
morphological class for each tumor.  Polypoid tumors were defined as those whose height is 
greater than one half their diameter, while flat tumors have heights less than one half their 
diameter. 
Tumors were classified as low-grade dysplasia if they had a mildly disorganized 
epithelium lined by hyperchromatic cells with nuclear pseudostratification.  Features used to 
classify tumors with high-grade dysplasia included back-to-back glands, high nuclear to 
cytoplasmic ratios, loss of cellular polarity and increased nuclear pleomorphism.  Tumors 
were scored as invasive when there was obvious penetration of dysplastic glands through the 
muscularis mucosa with associated desmoplastic stromal response. 
 
 Mutation analysis.  Tumor epithelium from H&E stained tumor sections were 
isolated using laser-assisted micro-dissection on a P.A.L.M. system (Zeiss MicroImaging) 
before isolating DNA with the PicoPure DNA Extraction Kit (Arcturus).  PCR was 
performed to amplify the segment of the Catnnb1 genomic region coding for the 
phosphorylation domain of CATNNB1 (5’ GCTGACCTGATGGAGTTGGA and 3’ 
GCTACTTGCTCTTGCGTGAA), exon 1 of Kras (5’ GCCTGCTGAAAATGACTGAG and 
3’ CCTCTATCGTAGGGTCGTAC) and codon 624 of Braf (5’ 
TTCCTTTACTTACTGCACCTCAGA and 3’ AAGCCCTTCAGTGTATTTCTCG 3’).  
PCR products were gel-purified and directly sequenced by the UNC Genome Analysis 
Facility.   
 Immunohistochemistry.  Tissue sections were deparaffinized in xylene and hydrated 
through a graded alcohol series.  Immunohistochemistry to detect CATNNB1 was performed 
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using a mouse anti-CATNNB1 antibody diluted 1:100 (Transduction Laboratories) with the 
M.O.M. kit (Vector Laboratories) and visualized using DAB (Zymed Laboratories).  Primary 
antibody incubations were performed over-night at 4°C.  
 
 Endoscopy.  Endsocopy was performed between 9 and 26 weeks after AOM 
injection (Fig. 2.1).  Direct visualization of colonic tumors in vivo was performed using a 
“Coloview system” (Karl Storz Veterinary Endoscopy).  Mice were supplied with food and 
water until the endoscopy was performed.  If fecal material obstructed the view of the 
endoscope, colons were flushed with 0.9% saline.  For the colonoscopies the mice were 
anesthetized with 1.5%-2% isoflurane and approximately 3-4 cm of the colon from the anal 
verge until the splenic flexure was visualized after inflation of the colon with air.  The 
colonoscopic procedures were digitally recorded on an AIDA® Compaq PC. 
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Results 
 
Genetic background influences colon tumor morphology.  We previously reported 
that significant differences exist in gross tumor size and morphology among AOM-induced 
tumors in mouse strains with tumors from KK/HIJ being 1.3-fold larger in average diameter 
than tumors from I/LNJ (Bissahoyo et al. submitted).  Morphometric analysis of H&E 
stained sections from KK/HIJ and I/LNJ mice validated these results (data not shown) and 
also reveal that AOM-induced colorectal tumors recapitulate two morphological growth 
patterns seen in human CRCs, outward growing polypoid and lateral growing flat (also called 
non-polypoid) cancers (Muto et al. 1985; Nasir et al. 2004; Speake et al. 2007) (Fig. 2.2A).  
To assess the influence of genetic background on tumor morphology, we quantified the 
number of tumors of each morphological class in AOM-treated KK/HIJ and I/LNJ mice (Fig. 
2.2B).  We found that KK/HIJ mice develop a significantly higher proportion of polypoid 
tumors (26/32) than I/LNJ mice, which predominantly develop flat tumors (19/23) (P = 
0.0001).  
To more accurately compare the sizes of polypoid and flat tumors, we determined the 
cross-sectional area at the midpoint of each tumor as a measure of maximal cross-sectional 
area.  Polypoid tumors (average area = 3.9 mm2) showed a 3.4-fold increase over flat tumors 
(average area = 1.14 mm2) in maximal cross-sectional area (P = 0.0001; Fig. 2.2B), similar to 
the difference observed for the height to width (H:W) ratio (polypoid tumors had a 3.2-fold 
larger average H:W ratio than flat tumors).  However, since the two morphological types 
occur preferentially in different strains, these comparisons could represent strain differences 
rather than morphological differences in growth.  To distinguish these possibilities, we 
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performed an inter-strain comparison of flat and polypoid tumors separately and found that 
KK/HIJ and I/LNJ mice do not differ significantly for either tumor morphology (Fig. 2.2C).  
These data demonstrate that tumor morphology is strongly influenced by strain, while tumor 
growth (size) is associated with the type of morphology and not directly by strain. 
 
Flat and polypoid tumors have similar mutational spectra.  Greater than 80% of 
human CRCs have mutations in the APC gene (Takahashi et al. 2000), and CATNNB1 
mutations, mutually exclusive with those in APC, occur in nearly 10% of human CRCs 
(Sparks et al. 1998).  Conversely, previous analyses of AOM-induced mouse polypoid 
colorectal tumors have reported frequent mutations in Catnnb1, while observing no 
mutations in Apc (Takahashi and Wakabayashi 2004).  The Catnnb1 mutations occurring in 
AOM-induced tumors cluster around codons 32-34, which codes for a portion of the 
phosphorylation domain of CATNNB1 that is required for ubiquitin-mediated degradation 
(Peifer et al. 1994).  A subset of AOM-induced tumors with mutations in codon 41 are 
reportedly associated with increased oncogenicity in rats (Koesters et al. 2001).  
To determine whether differences in tumor morphology are associated with different 
transforming mutations, we compared the distribution of Catnnb1 mutations between strains 
and morphologies, all of which show stabilization and nuclear localization of CATNNB1 
(Fig. 2.3A).  Of the KK/HIJ tumors analyzed for the presence of Catnnb1 mutations, 17 of 21 
(81%) contained mutations in codons 32-41 of Catnnb1, similar in frequency and distribution 
to those observed in the I/LNJ tumors with 16 of 17 (93%) containing Catnnb1 mutations 
and indicating a strain-independent frequency of Catnnb1 mutations.  Similarly, 16 of 18 
(89%) polypoid tumors contained Catnnb1 mutations compared to 12 of 14 (86%) flat 
 30 
tumors suggesting that differences in Catnnb1 mutation frequency or distribution do not 
underlie morphological differences (Fig. 2.3B).  In contrast to a previous report stating that 
codon 41 mutations in Catnnb1 are associated with greater “oncogenic potential” (Koesters 
et al. 2001), we did not observe a correlation between the distribution of Catnnb1 mutations 
and oncogenic potential (Fig. 2.3C).  If anything, codon 41 mutations in Catnnb1 are less 
frequently associated with higher-grade tumors than those in codons 32-34.  
 Although mutations in Kras are frequently associated with more progressed colorectal 
tumor pathology (Fujimori et al. 1994; Minamoto et al. 1994; Yamagata et al. 1994; Ohnishi 
et al. 1997; Olschwang et al. 1998; Takahashi et al. 2000; Umetani et al. 2000; Yashiro et al. 
2001; Yokoyama et al. 2005), previous reports are conflicting on whether flat tumors contain 
fewer Kras mutations than polypoid tumors (Fujimori et al. 1994; Minamoto et al. 1994).  
Since the vast majority of reported Kras mutations occur in codons 12 or 13 (Umetani et al. 
2000), which encodes the GTP-hydrolysis domain, we analyzed these codons for Kras 
mutations.  Only one Kras mutation (exon 13) was found in 15 polypoid tumors analyzed 
(7%) and one Kras mutation (exon 12) was found in 15 flat tumors (7%), occurring in 
KK/HIJ and I/LNJ, respectively.  Mutations in BRAF, coding for a signal mediator 
downstream of KRAS and mutually exclusive with KRAS mutations are associated primarily 
with serrated adenomas of the colon (Davies et al. 2002; Chan et al. 2003; Mercer and 
Pritchard 2003; Jaworski et al. 2005).  Consequently, we assessed the mutational status of 
Braf codon 624, corresponding to the reported BRAF codon 599 mutations in human serrated 
CRCs, in polypoid and flat tumors.  No Braf mutations were found in any of the tumors 
analyzed. 
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Growth pattern or mutational spectra are not associated with stromal 
expansion.  Colorectal adenomas are frequently associated with proliferation of cancer-
associated stroma, which can function as a source of growth signals (Powell et al. 1999; 
Adegboyega et al. 2002) and in theory modulate the pattern of tumor growth.  
Immunostaining of polypoid and flat tumor sections for alpha-smooth muscle actin 
(ACTA2), a marker of myofibroblasts, showed subsets of tumors from both morphologies 
with extensive stromal expansion (Fig. 2.4), indicating that differences in growth patterns 
between polypoid and flat tumors is not due to differential expansion of the tumor-associated 
myofibroblasts.  Furthermore, there was extensive stromal expansion in tumors with wildtype 
Kras and Braf, suggesting that tumors can acquire stromal hyperproliferation without 
mutations in the KRAS pathway. 
 
Flat invasive carcinomas arise through flat adenoma intermediates.  Some 
reports have suggested that flat colorectal carcinomas develop either through a polypoid 
intermediate by ulceration and sloughing off of a polyp or through formation of a flat 
adenoma intermediate (Rubio and Shetye 1994; Kashida and Kudo 2006).  However, 
contrasting models have posited that flat carcinomas arise de novo without an adenomatous 
intermediate (Spjut et al. 1979; Crawford and Stromeyer 1983; Kuramoto and Oohara 1989; 
Owen 1996; Wada et al. 1996).  To distinguish between these conflicting models, we utilized 
endoscopy to visualize and serially follow tumor growth patterns from initiation through 
progression to invasive carcinoma.  Polypoid tumors were first observed as small but notably 
raised lesions that tended to grow outward (vertically) into the lumen (Fig. 2.5A).  
Conversely, flat tumors first appeared as slightly raised, lateral (horizontally) growing lesions 
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with a central depression that over time became larger but remained flat (Fig. 2.5B and 2.6A). 
Polypoid tumors tended to increase in size more quickly than flat tumors.  The polypoid and 
flat tumor morphologies observed with endoscopy were consistent with the histological 
characterizations. 
No flat tumors were observed that progressed to a polypoid morphology nor did we 
observe evidence of ulceration in vivo (Fig. 2.6A).  Histological analysis revealed that flat 
tumors are capable of progressing to invasive carcinoma, and in all cases, adenomatous 
components were observed (Fig. 2.6B and C).  Taken together, these data indicate that flat 
invasive carcinomas developing in the AOM model do not arise de novo, but rather through a 
flat adenoma intermediate without ever exhibiting a polypoid morphological stage.  
Furthermore, no significant differences exist between polypoid and flat morphologies in the 
proportion of invasive carcinomas (polypoid – 17%, flat – 15%). 
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Discussion 
 
There is an increasing awareness that flat CRCs, originally described in Japan, occur 
in western countries. Recent reports show that the prevalence of CRCs with flat 
morphologies are not geographically constrained and are generally under-appreciated due to 
the greater difficulty of their detection during routine colonoscopies (Saitoh et al. 2001; 
Church et al. 2004; Soetikno et al. 2006).  Using the AOM mouse model of human CRC, we 
demonstrate that genetic background strongly influences the morphological growth pattern of 
CRCs, independent of the initiating mutations.  We found that AOM-treated mice develop 
two predominant morphological varieties of colorectal tumors, which show similarity to 
human CRCs with polypoid and flat morphologies. 
Azoxymethane predominantly induces large, outward growing polypoid tumors in 
KK/HIJ mice, while in I/LNJ mice, AOM predominately induces smaller, lateral growing flat 
tumors, supporting the importance of genetic background in determining the growth pattern 
of CRCs.  Interestingly, polypoid and flat tumors have a similar mutational spectra with 
equivalent Catnnb1 and Kras mutation frequencies and an absence of Braf mutations, 
indicating that differential initiating mutations are not the underlying mechanism driving 
morphological growth.  Similarly, we observed extensive growth of ACTA2-positive stroma 
in a subset of both polypoid and flat colorectal tumors, uncorrelated with Catnnb1 and Kras 
mutation status, indicating that myofibroblast expansion is also not responsible for the 
differential growth patterns. 
The predominant initiating mutations in human CRCs result in the inactivation of 
APC with consequential stabilization of CATNNB1 (Reviewed in (Fearnhead et al. 2001).  
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However, up to 50% of human CRCs that have no detectable APC mutation contain 
CATNNB1 mutations resulting in ubiquitination-resistant, stabilized CATNNB1 protein 
(Sparks et al. 1998).  Consistent with previous reports (Takahashi et al. 2000; Koesters et al. 
2001), we found that Catnnb1 mutations tended to cluster around codons 32-34, which codes 
for a portion of the phosphorylation domain of the mature protein.  
 Previous data have suggested that extended dimethylhydrazine (DMH), a presursor to 
AOM, treatment results in a higher proportion of tumors with Catnnb1 mutations in codon 41 
as opposed to codons 32-34 (Koesters et al. 2001).  The conclusions offered to explain these 
results were that extended carcinogen treatment results in a higher incidence of mutations in 
codon 41, which normally account a minority of mutations observed with shorter carcinogen 
treatment, but conferring higher “oncogenic potential”.  Contrary to this theory, we found no 
correlation between the site of Catnnb1 mutation and tumor oncogenicity.  Based upon the 
differential oncogenicity model, one would expect that tumors bearing codon 41 mutations 
would have a tendency toward more advanced stages.  Yet, we did not observe tumors with 
codon 41 mutations as being any more advanced than those with mutations in codons 32-34.  
Although the former study was performed in rats, this difference is unlikely a species-
specific difference since both rats and mice have similar distributions of Catnnb1 mutations 
after five weeks of DMH treatment (Koesters et al. 2001).  An alternative possibility is that 
mutations in codon 41 of Catnnb1 render cells more resistant to cell death caused by 
additional carcinogen treatment.  
 Significant attention has been paid to the role of secondary mutations in human 
CRCs, particularly KRAS (Forrester et al. 1987; Vogelstein et al. 1988; Minamoto et al. 1994; 
Yamagata et al. 1994; Olschwang et al. 1998).  The frequency of Kras mutations we detected 
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in AOM-induced flat tumors is similar to that observed in polypoid tumors and is consistent 
with findings for human flat tumors (Minamoto et al. 1994; Olschwang et al. 1998; Yashiro 
et al. 2001).  However, the relatively low frequency of Kras mutations in AOM-induced 
polypoid tumors contrasts with that reported in human polypoid tumors (Vogelstein et al. 
1988; Yamagata et al. 1994; Umetani et al. 2000; Yashiro et al. 2001.  Vogelstein and 
coworkers proposed that Kras mutations were significantly more common in larger tumors 
{Vogelstein, 1988 #13).  Based on the great variability in size of non-Kras mutant tumors, 
our data suggests that tumor size variation occurs independent of Kras mutation status.      
 There has been considerable controversy over the origin of flat invasive colorectal 
carcinomas of the colon.  While some models predict that flat carcinomas form through the 
adenoma-carcinoma sequence, including a polypoid stage with subsequent ulceration, other 
models predict a de novo pathway whereby flat CRCs arise directly as carcinomas without an 
adenoma intermediate.  Here we used serial endoscopy and histology to visualize the initial 
formation and subsequent progression of polypoid and flat colorectal tumors that arise in the 
AOM mouse model of human CRC and demonstrate that flat invasive carcinomas do not 
arise de novo, but are preceded by flat adenomas without progression through a polypoid 
stage, consistent with original reports describing human flat CRCs (Muto et al. 1985; Wolber 
and Owen 1991).  
In this study, we combined use of the AOM mouse model of human CRC with 
endoscopy to directly visualize the initiation and progression of flat and polypoid tumors in 
vivo.  Our results demonstrate that flat and polypoid colorectal tumors are distinct entities, 
despite having similar mutational spectra.  One explanation for this may be due to the 
presence of as yet unknown strain-specific genetic modifiers that influence tumor shape.  
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Furthermore, it is possible that these influences are rendered not in a tumor-autonomous 
manner but rather through strain-specific colon micro-environments.  Since CRCs with flat 
morphologies are under detected in western societies during routine colonoscopies, the AOM 
models reported here can support investigations into the unique molecular characteristics of 
flat CRCs and should aid in the development of new methods for their detection, prevention 
and treatment.  
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Figure 2.1.  Experimental timeline for azoxymethane-induced CRC and analysis. Tumor 
induction for initial histologic studies was done with four weekly azoxymethane injections 
(black arrowheads), whereas colonoscopic and progression analyses were done using six 
weekly azoxymethane injections (black plus gray arrowheads). Endoscopy was performed 
from 9 to 20 weeks after the first azoxymethane injection (white arrowheads). Due to large 
tumors resulting in intestinal obstruction, KK/HIJ mice were sacrificed at 20 weeks rather 
than 26 weeks post-azoxymethane induction 
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Fig. 2.2. Morphometric analysis reveals differences in tumor physical variables. A, 
representative examples of polypoid (magnification, ×1.6; bar, 1 mm) and flat 
(magnification, ×5; bar, 1 mm) gross tumor histology. B, height, width, and area 
measurements taken in cross-sections near the center of each tumor reveals that tumors from 
KK/HIJ have a greater height-to-width ratio than tumors from I/LNJ, which corresponds to 
differences between polypoid and flat tumors. The ratio of height-to-width is expressed as 
log2. C, interstrain comparisons between polypoid and flat height-to-weight ratios show 
strain-independent differences in polypoid and flat tumor size. 
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Figure 2.3.  Nuclear localization and mutational spectra of Catnnb1 is similar between 
polypoid and flat colorectal tumors.  A, CATNNB1 immunostaining in representative tumors 
(magnification x10, bars, 100 microns).  B, the frequency and distribution of Catnnb1 
mutations is similar in polypoid and flat tumors.  C, the distribution of Catnnb1 mutations 
does not distinguish low-grade from high-grade colorectal tumors.  Low-grade (), high-
grade/invasive carcinomas (). 
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Figure 2.4. Polypoid and flat adenomas display similar levels of stromal expansion. ACTA2 
immunostaining of representative normal colon, polypoid, and flat tumors. 
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Figure 2.5. Growth and progression of polypoid and flat tumors observed in vivo through 
serial colonoscopy. A, KK/HIJ mouse at week 17 with three polypoid tumors (white arrows) 
and at week 20 with the same cluster of three polypoid tumors plus an additional new 
polypoid tumor (black arrow). B, I/LNJ mouse at week 17 with a single flat tumor containing 
a central depression (black arrow) and at week 20 with three flat tumors (white arrows) in 
the same location as week 17. 
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Figure 2.6.  Flat carcinomas arise through a flat adenoma intermediate. A, no visible tumors 
during an initial colonoscopic examination at week 9 and a single flat tumor in the same 
mouse at week 12 (shiny area in week 9 image is fecal matter). B, representative flat invasive 
carcinoma arising from a flat adenoma (magnification, ×1.6; bar, 1 mm). C, enlargement of 
invasive carcinoma in B, characterized by malignant glands invading through the muscularis 
mucosa (arrow) with mild stromal desmoplasia and pools of submucosal mucin (arrowheads; 
magnification, ×10; bar, 100 microns). CRC Pathology 
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Comparison of Flat and Polypoid Colorectal Tumor Gene Expression 
Signatures 
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Abstract 
 
 
The majority of human colorectal cancers (CRC) have a polypoid morphology. 
Increasing evidence suggests that colorectal cancers (CRC) with a flat morphology comprise 
a measurable proportion of CRC in the United States.  Using the AOM model of human CRC 
we previously demonstrated that the KK/HIJ and I/LNJ mouse strains predominantly develop 
colonic tumors with polypoid and flat morphologies, respectively.  KK/HIJ mice 
predominantly form large polypoid CRCs while I/LNJ mice predominantly form smaller flat 
CRCs.  To elucidate the mechanism(s) that predisposes to the formation of the flat or 
polypoid morphology, we performed whole-genome microarray analysis to compare gene 
expression profiles between flat and polypoid colorectal adenomas.  Despite these distinct 
differences in morphology, flat and polypoid adenomas showed strikingly similar gene 
expression profiles.  Using significance analysis of microarray (SAM), we found no 
significant differences in gene expression between flat and polypoid adenomas, however we 
did observe significant and mutually exclusive changes in gene expression between flat and 
polypoid adenomas compared to the normal colon.  Based on these findings we hypothesize 
that the mechanism(s) which control formation of flat versus polypoid cancers lies within the 
normal colon and is strongly influenced by genetic background.  We present here a list of 
candidate genes which are differentially expressed between flat and polypoid tumors 
compared to the normal colon that may function in the determination of tumor morphology. 
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Introduction 
 
Colorectal cancer (CRC) is the third most diagnosed cancer in the United States and 
is the second most common cause of cancer-related deaths with an estimated 154,000 new 
cases and 52,000 deaths annually (American Cancer Society, 2007).  Colonoscopy is 
currently the most accurate method for the detection and removal of colonic neoplasms. 
However there is growing evidence that CRCs with a lateral growth leading to a flat 
morphology are more difficult to detect and missed a higher frequency than cancers with the 
more typical vertical growth and polypoid morphology (Kuramoto and Oohara 1989; Church 
et al. 2004; Ross and Waxman 2006; Soetikno et al. 2006). Consequently, flat CRCs are 
associated with a higher incidence of invasive disease.  
Flat CRCs were initially identified as a distinct morphological entity in Japan nearly 
30 years ago and for much of this time have been considered uncommon in western countries 
(Kariya et al. 1977; Muto et al. 1985; Saitoh et al. 2001; Hurlstone et al. 2007; Speake et al. 
2007).  However, recent studies suggest that the apparent lower incidence of flat CRCs in the 
United States is likely the result of higher rates of missed detection due to the difficulty in 
visualizing these lesions during colonoscopy (Saitoh et al. 2001). Thus, a better 
understanding of the mechanisms that determine the morphological growth pattern of CRCs 
may provide new methods for detecting flat lesions. 
Although several studies have examined the underlying molecular etiology of 
different CRC morphologies, the mechanisms that led to differential formation of flat and 
polypoid CRCs are unknown (Fujimori et al. 1994; Minamoto et al. 1994; Wada et al. 1996). 
Using the azoxymethane (AOM) mouse tumor model of human CRC with different mouse 
strains, we previously demonstrated that genetic background strongly influences CRC 
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morphology; 83% of AOM-induced colon tumors arising in I/LNJ mice are flat compared to 
only 19% in KK/HIJ mice.  Unexpectedly, flat and polypoid tumors have a similar 
mutational spectra (Uronis et al. 2007). 
In order elucidate the underlying molecular differences between flat and polypoid 
tumors, we performed a whole-genome gene expression analysis.  We found that flat and 
polypoid colorectal tumors have remarkably similar gene expression profiles despite their 
distinct morphologies.  However, we uncovered numerous strain-dependent differences 
between flat tumors and normal colon and between polypoid tumors and normal colon that 
are mutually exclusive.  Gene ontology analysis suggests that subsets of these genes are 
involved with biological processes that may influence CRC morphology.  Based on these 
findings we hypothesize that flat and polypoid CRC morphologies are not mediated by 
cancer-specific differences but rather by the host colon microenvironment, which is 
determined by genetic background. 
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Materials and Methods 
 
Mice and colon samples.  KK/HIJ and I/LNJ mice were obtained from the The 
Jackson Laboratory.  KK/HIJ and I/LNJ mice between two and four months of age were 
injected intra-peritoneally with 10 mg/kg body weight azoxymethane (AOM) (Sigma-
Aldrich) once a week for six weeks as previously described (Bissahoyo et al. 2005; Uronis et 
al. 2007).  KK/HIJ and I/LNJ mice were sacrificed at 5 and 6 months after the first AOM 
injection, respectively, due to the fact that KK/HIJ mice formed large obstructive tumors.   
Upon sacrifice, colons were removed from the cecum to the rectum, gently flushed with PBS, 
placed on filter paper and splayed longitudinally.  Flat and polypoid tumors and normal colon 
tissues were collected, snap frozen in liquid nitrogen and stored at -80°C.  Mice were housed 
in ventilated racks and provided 5010 chow (LabDiet) and water ad libitum in an Association 
for Assessment and Accreditation of Laboratory Animal Care (ALAAC)-approved animal 
facility.  All experiments were approved by the UNC Institutional Animal Care and Use 
Committee.  
 
Microarray analysis.  Total RNA was isolated from normal colon and tumors using 
Trizol®.  Sample and reference RNAs were amplified and labeled with Cy5 and Cy3 
respectively using the Low RNA Input Linear Amplification Kit (Agilent Technologies) as 
previously described (Syed and Threadgill 2006).  Hybridizations were performed using 
Whole Mouse Genome Oligo Microarrays (Agilent Technologies, Cat# G4122F) and 
scanned using an Agilent Array Scanner.  Features were extracted by Agilent image analysis 
software, and the data was deposited into the UNC microarray database 
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(http://genome.unc.edu).  The data was then batch extracted, Lowess normalized and 
subjected to cluster analysis. Genes were omitted from further analysis if they were either 
absent or flagged for poor feature quality in at least two of the three biological replicates in 
each experimental group.  
Statistical analyses were performed using two-class unpaired significance of 
microarray analysis (SAM) with a false discovery rate (FDR) of 5% or less using software 
obtained from Stanford University.  Average linkage hierarchical cluster analysis was 
performed using Cluster and data visualized using Java Tree View (Eisen laboratory, 
Stanford University).  Gene ontology analyses were performed using the Ontology Tree 
Machine (Vanderbilt University).  
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Results 
 
Flat and polypoid tumors are molecularly similar.  In contrast to a recent report 
showing that human flat and polypoid colorectal adenomas were grouped independently by 
unsupervised cluster analysis, our work using the AOM mouse model of colorectal cancer 
shows that flat and polypoid adenomas do not cluster independently however they were 
distinguished from normal colon tissue (Fig 3.1).  Furthermore, tumor samples subsequently 
clustered by strain, demonstrating the influence of genetic background on colorectal adenoma 
gene expression profiles (Fig 3.1).  To more definitively demonstrate the similarity between 
flat and polypoid gene expression profiles, we performed unsupervised cluster analysis on 
flat and polypoid adenomas using gene sets 1 and 2  (Fig. 3.2).  These mutually exclusive 
gene sets represent genes differentially expressed between flat (gene set 1) and polypoid 
(gene set 2) adenomas compared to the normal colon.  Again, flat and polypoid adenomas 
showed mixed cluster results (Fig 3.2B).  Taken together with the similar flat and polypoid 
profiles shown in Fig 3.1, these data suggest that while there are transcription-mediated 
differences that may account for determination of flat and polypoid adenomas morphology, 
the mechanism(s) that direct this process are inherent to the normal colon and not to the 
adenomas themselves.  
Using SAM, we compared flat and polypoid adenomas for differential gene 
expression patterns to reveal candidate genes that may shed light on the mechanism 
underlying the development of flat and polypoid morphologies.  We observed no significant 
differences when directly comparing flat and polypoid adenoma gene expression profiles 
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(Table 3.1).  However, we did observe a variety of differentially-expressed transcripts 
between both flat and polypoid adenomas compared to normal colon tissue which is 
consistent with a previous report (Table 3.2) (4).  
Kita and coworkers reported that 180 genes are differentially regulated between 
human flat adenoma and the normal colon including matrix metalloproteinase 7 (MMP7), 
pleckstrin-like homology domain A1 (PHLDA1), somatostatin (SST), ATP-binding cassette 
2 (ABCG2), chromogranin A (CHGA), claudin 8 (CLDN8), aquaporin 8 (AQPN 8) and 
glucagon (GCG) (Kita et al. 2006).  Consistent with these findings we also observed these 
transcripts to be differentially expressed between flat adenoma and normal colon tissue.  
However, their work was limited to a comparison of flat adenoma and normal colon leaving 
the possibility that these transcripts are not mutually exclusive with those differentially 
expressed in polypoid adenomas and therefore provide little information as to the mechanism 
that differentiates between flat and polypoid CRC development.  We therefore compared 
transcripts between both flat and polypoid adenomas with normal colon in search of 
differences that are unique to either flat or polypoid adenomas compared to the normal colon.  
Interestingly, we found that (MMP7), (PHLDA1), (SST), (ABCG2), (CHGA), (CLDN8), 
(AQPN 8) and (GCG) are differentially expressed in polypoid as well as flat adenomas 
compared to the normal colon again underscoring the similarity between flat and polypoid 
colorectal adenomas.  However, there still remains the possibility that mutually exclusive 
differences exist between each morphology and the normal colon that may drive 
determination of CRC morphology.  We therefore used Gene Spring® to search for genes 
that fit this criteria (Fig 3.2A).  Using SAM we compared differential gene expression 
profiles between both flat and polypoid adenomas and normal colon tissue.  We determined 
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that 2,055 and 2,949 genes are differentially expressed by at least 2-fold between flat and 
polypoid colorectal adenomas compared to normal colon respectively.  In comparing genes 
that are differentially expressed between flat and polypoid adenomas compared to normal 
colon, we found 223 and 1,117 that are unique to flat and polypoid adenomas respectively.  
When all adenomas irrespective of morphology were compared to normal colon, a similar 
number of differentially expressed genes (2,460) were discovered. In the context of this 
study, there appears to be an interesting lack of disparity between gene expression profiles of 
flat and polypoid adenomas.  Considering this and given the large number of mutually 
exclusive genes which are differentially expressed between flat and polypoid adenomas 
compared to the normal colon, it seems reasonable to suggest that a transcriptionally-
mediated mechanism which drives flat versus polypoid adenoma development may not be 
inherent to the tumors themselves, rather, we hypothesize that the mechanism lies within the 
micro-environment of the normal colon. 
 
Colorectal adenoma morphology may be determined by the host colon 
microenvironment.  We previously showed that KK/HIJ and I/LNJ mice differ significantly 
with their respective frequencies of polypoid and flat tumors. Considering the lack of 
differences in transcriptional expression between flat and polypoid adenomas, we considered 
that genetic background may influence the predisposition to development of distinct tumor 
morphologies.  To narrow our search for strain-dependent genes that may influence 
colorectal tumor morphology, we used SAM to generate strain-dependent transcriptional 
profiles and found 582 genes to be differentially expressed between KK/HIJ and I/LNJ 
normal colon and tumor tissues.  We found 72 genes  (set 4: 19 and set 5: 53) that were up or 
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down-regulated exclusively in either flat or polypoid adenomas compared to normal colon 
that also differed by strain.  
  Among the 72 genes comprising sets 4 and 5, we found a variety of candidate genes 
the products of which may influence tumor morphology (Table 3.2).  The functions of these 
genes include transcription regulation, inflammatory response, cytokine activity, cell 
adhesion, chemotaxis, extracellular matrix components, Wnt signaling and G-protein coupled 
protein signaling.   
To identify candidate genes that warrant further investigation, we performed gene 
enrichment analysis using the Gene Ontology Tree Machine (Vanderbilt University) to 
associate candidates with known biological processes.  We analyzed gene sets 1 & 4 and 2 & 
5 for gene ontology categories that were relatively enriched (p < 0.01 or less).  To account 
for false positive candidates identified by performing multiple statistical tests, we assigned 
cut-off p-values of 0.001 and 0.00005 and for flat and polypoid adenoma-associated 
pathways respectively, thereby increasing the probability that candidates are truly involved in 
the mechanisms underlying tumor morphogenesis.  Analysis of gene sets 1 & 4 showed 
significant enrichment in 38 gene ontology categories including ATP binding (p = 0.000011), 
mitotic cell cycle (p = 0.000006), DNA metabolism (p = 0.0000014), DNA replication 
initiation (p = 0.00000023), DNA-dependent ATPase activity (p =0.000084) and 
chromosome-related functions  (p =0.0000016).  Gene sets 2 & 5 showed significant 
enrichment in 62 categories including elevation of interleukin receptor activity (p = 0.00003), 
cell surface receptor-linked signal transduction (p = 0.001), inorganic ion transport (p = 
0.001), defense response (p = 0.0006), and phospholipid binding (p = 0.0008) (Table 3.3).  
While this analysis suggests that these processes that may function in colorectal tumor 
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morphogenesis, additional studies need to be performed to obtain empirical evidence of their 
role in flat colorectal tumor formation.  
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Discussion 
 
There is growing awareness that flat CRCs are not geographically constrained as was 
once believed.  Rather, the perceived disparity in flat tumor incidence in the United States is 
the result of difficulty in detecting these more subtle lesions during routine colonoscopy, 
which likely contributes to the higher rates of invasive cancer associated with this 
morphology (Saitoh et al. 2001; Church et al. 2004; Soetikno et al. 2006).  Although some 
have attributed flat CRC morphologies to relatively infrequent KRAS mutations compared to 
their polypoid counterparts (Minamoto et al. 1994; Olschwang et al. 1998; Yashiro et al. 
2001), there has been little progress in truly understanding their underlying etiology.  
Using the AOM mouse model of human colorectal cancer, we previously showed that 
flat and polypoid colorectal adenomas have a similar frequency and distribution of mutations 
in Catnnb1, Kras and Braf and that both morphologies contain similar amounts tumor 
associated stroma (Uronis et al. 2007).  Consistent with these findings, we have shown here 
using whole-genome microarray analysis that flat and polypoid colorectal adenomas display 
remarkably similar gene expression profiles.  Taken together with the apparent strain-
dependent influence on tumor morphology, we propose that the mechanism responsible for 
determining tumor morphology does not lie within the tumors themselves but is provided by 
the surrounding normal colon microenvironment and is strongly influenced by genetic 
background. 
In comparing gene lists that differ respectively between the two morphologies and 
normal colon with genes that have 2-fold or greater differences in expression between the 
KK/HIJ and I/LNJ strains, we generated a list of 72 genes that warrant further investigation 
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as candidates for involvement in the mechanism of colorectal tumor morphology 
determination.  Among them, several genes (Ccl28, Ccl5, Il6, Fbln2, Ifng, T2bp and 
Col17a1) have known cytokine, chemotaxis, inflammatory or extracellular matrix functions, 
which make them attractive candidates for working toward the mechanism of colorectal 
tumor morphogenesis.  It is possible that cytokine signaling between colorectal adenomas 
and the neighboring normal colon may influence the direction of tumor growth.  For 
example, secretion of mitogenic or chemotactic stimuli near the periphery of early stage 
tumors could promote lateral rather than outward polypoid tumor growth resulting in the 
formation of a flat adenoma.   
In support of this hypothesis, Hirayasu and co-workers proposed that tumor-
neighboring normal mucosa influences CRC growth (Hirayasu et al. 2002).  They 
demonstrated that vasoactive intestinal peptide (VIP), a protein known to influence cell 
proliferation (Haegerstrand et al. 1989; Pincus et al. 1990; Koh et al. 1997) was found at 
significantly greater levels in neighboring normal mucosa than in remote normal mucosa 
(Hirayasu et al. 2002).  While the authors did recognize the possibility that the higher VIP 
levels in the neighboring mucosa were secondary to the growth of the colorectal carcinoma, 
they did point out the presence of aberrant histological characteristics such as elongated 
crypts and increased goblet cell number at the lateral invasive front of the tumor which is 
suggestive of a response to the colon microenvironment.  Consistent with their observations, 
we also observed elongated crypts at the lateral edges of flat colorectal adenomas in our 
study that may serve as an indicator for lateral tumor growth.   
In this study, we have used the AOM mouse model of human CRC to investigate the 
mechanism of CRC morphology determination.  Our results show that in our system, flat and 
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polypoid colorectal adenomas are strikingly similar at the transcriptional level though both 
morphologies show differences in transcript level compared to the normal colon suggesting 
that the mechanism driving flat and polypoid colorectal tumor determination lies within the 
host colon and not within the tumors themselves.  Furthermore, gene ontology analysis 
revealed enrichment of a number of candidate genes known to contribute to a variety of 
biological processes which may in turn play a role in the process of colorectal tumor 
morphogenesis.  This study has provided the framework by which future studies may be able 
to more accurately determine the unique molecular characteristics driving the development of 
flat CRCs in humans. 
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Figure 3.1.  Hierarchical clustering of colorectal adenomas.  Normal colon, flat- and 
polypoid adenoma RNA samples were analyzed on 4X 44K microarrays.  Clustering shows 
two distinct classes formed between normal colon and adenomas as well as strong strain-
dependent clustering among tumors. 
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Table 3.1.  List of genes different by 2-fold or more between colorectal adenomas 
and normal colon tissues  
Comparison Significant Genes  
All flat adenomas v. all normal colon 2055  
All polypoid adenomas v. all normal colon 2949  
All adenomas v. all normal colon  2460  
I/LNJ normal colon v. KK/HIJ normal colon 610  
All I/LNJ adenomas v. all KK/HIJ adenomas  918  
All ILNJ v. KKHIJ tissues 582  
All flat v all polypoid adenomas none  
ILNJ flat v ILNJ polypoid adenomas none  
KKHIJ flat v KKHIJ polypoid adenomas none  
SAM was performed to identify genes that were differentially expressed by 2-fold or 
greater with a false discovery rate of 5% or less.  
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Figure 3.2.  Gene sets differentially expressed between each colorectal adenoma 
morphology and normal colon.  A.  Venn diagram showing genes differentially regulated 
between morphology, strain and normal colon vs. tumor.  1. Genes differentially expressed 
between flat adenoma and normal colon tissue.  2.  Genes differentially expressed between 
polypoid adenoma and normal colon tissue.  3.  Genes differentially expressed between 
KK/HIJ and I/LNJ mice.  4.  Genes differentially expressed between flat adenoma and 
normal colon tissue as well as between KK/HIJ and I/LNJ mice.  5. Genes differentially 
expressed between polypoid adenoma and normal colon tissue as well as between KK/HIJ 
and I/LNJ mice.  Gene sets 1 and 2 are mutually exclusive as are 4 and 5.  B.  Unsupervised 
cluster analysis performed using gene sets 1 and 2. 
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Table 3.2A.  List of genes with a 2-fold or greater difference between flat 
adenoma and normal colon tissue as well as between KK/HIJ and I/LNJ mice. 
Gene Symbol Common Name 
P2ry6 Pyrimidinergic receptor P2Y 
Col17a1 Procollagen XVII 
Ifng Interferon gamma 
Il18r1 Interleukin 18 receptor 1 
T2bp Traf2 binding protein 
Sox11 SRY-box containing gene 11 
Olfm4 olfactomedin 4 
Ly6e lymphocyte antigen 6 complex 
Myo7a myosin VIIa 
Clca2 calcium activated chloride channel  
Lyzs lysozyme 
Rbp2 retinoid binding protein 2 
Neu3 neuramidase 3 
RIKEN  RIKEN clone:E330014L15 
Sftpd surfactant associated protein D 
RIKEN A630023P12 Rik 
RIKEN 1600029D21Rik 
Riken clone:E230011F24 
SAM was performed to identify genes that were differentially expressed by 2-fold or 
greater with a false discovery rate of 5% or less. 
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Table 3.2B. List of genes with a 2-fold or greater difference between polypoid 
adenoma and normal colon tissue as well as between KK/HIJ and I/LNJ mice. 
Gene Symbol Common Name 
Sfrp1 secreted-frizzeled-related sequence protein 1 
Ccl28 chemokine (C-C motif) ligand 28 
Il6 Interleukin 6 
Fbln 2 Fibulin 2 
Gpr84 G protein-coupled receptor 84 
Ccl5 chemokine (C-C motif) ligand 5 
Trim 12 tripartite motif protein 12 
Saa1 serum amyloid A1 
Srd5a2 steroid 5 alpha-reductase2 
Sdh1 sorbitol dehydrogenase 
Atad2 AtPase family, AAA domain containing 2 
Mthfd2 methylenetetrahydrogenase 
Prok2 prokineticin 2 
Cbr3  carbonyl reductase 
Lgals7 lectin, galactose binding, soluble 7 
Slc3a1 solute carrier family 3, member 1 
Xlr4 X-linked lymphocyte-regulated 
RIKEN clone:A730055B01 
none mKIAA0275 
RIKEN clone: 7330405M08 
Xlr3b x-linked lymphocyte-regulated 
RIKEN 1300007L22Rik 
RIKEN 2810037C14Rik 
RIKEN 9230105E10Rik 
RIKEN 2600010E01Rik 
RIKEN clone:230066H11 EST 
RIKEN 9430071P14 
LOC209387 triparite motif protein 30-like 
RIKEN A330049M08Rik 
NA ubiquitin specific protease 53 
Q9erk2 neprilysin-like peptidase gamma 
cDNA BC015286 
Akr1c12 aldo-keto reductase family 1 
Ces5 carboxylesterase 5 
5V327 similar to pleckstrin homology domain 
RIKEN clone:1500004K09 
RIKEN clone:7120489D09 
RIKEN KIAA1154 
Tmem45b transmembrane protein 45b 
SAM was performed to identify genes that were differentially expressed by 2-fold 
or greater with a false discovery rate of 5% or less. 
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Table 3.2B. List of genes with a 2-fold or greater difference between polypoid 
adenoma and normal colon tissue as well as between KK/HIJ and I/LNJ mice. 
Gene 
Symbol Common Name 
RIKEN clone:5031425E22 
Nov nephroblastoma over-expressed 
RIKEN 2410008J05Rik 
RIKEN 2310032FO3Rik 
Prlpb prolactin-like protein B 
SAM was performed to identify genes that were differentially expressed by 2-fold or 
greater with a false discovery rate of 5% or less.  
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Table 3.3.  Biological processes and pathways showing significant enrichment of 
genes differentially expressed between polypoid adenoma and normal colon 
Pathway/Category 
Enriched 
No. Genes 
associated 
with process 
(observed) 
No. Genes 
associated 
with process 
(expected) 
Significance 
ATP binding 60 34.4 p = 0.000011 
Mitotic cell cycle 19 5.9 p = 0.000006 
DNA metabolism 36 15.3 p = 0.0000014 
DNA replication 
initiation 7 0.5 p = 0.00000023 
DNA-dependent 
ATPase activity 6 0.77 p = 0.000084 
Chromosome function 23 7.5 p = 0.0000016 
Gene ontology was performed using the Ontology Tree Machine.  Processes with a p-
value of 0.00005 or less were considered significant 
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Table 3.4.  Biological processes and pathways showing significant enrichment of 
genes differentially expressed between polypoid adenoma and normal colon 
Pathway/Category 
Enriched 
No. Genes 
associated with 
process (observed) 
No. Genes 
associated with 
process (expected) 
 Significance 
 
interleukin receptor 
activity 4 0.18 p = 0.00003 
cell surface receptor-
linked signal 
transduction 15 6.3 p = 0.001 
inorganic anion 
transport 5 0.77 p = 0.001 
defense response 8 1.9 p = 0.0006 
phospholipid binding 6 1.1 p = 0.0008 
Gene ontology was performed using the Ontology Tree Machine.  Processes with a p-
value of 0.001 or less were considered significant 
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Introduction 
 
Our underling hypothesis in these studies is that flat and polypoid colorectal cancers 
are distinct entities that are genetically determined.  We originally hypothesized that the 
mechanism underlying the determination of flat and polypoid CRCs was tumor specific.  
However, our studies demonstrated that flat and polypoid CRCs are remarkably similar at the 
molecular level.  Given our findings it seems likely that the mechanism driving the growth 
pattern of these morphologies is inherent to the host normal colon.  To test our hypotheses, 
we used the azoxymethane (AOM) mouse model of human colorectal cancer (CRC) in 
combination with several mouse strains that demonstrate variable expressivity of flat and 
polypoid CRC morphologies to (1) compare and contrast the histopathology and mutational 
status of flat and polypoid colorectal tumors; (2)  study the continuous development of flat 
and polypoid colorectal cancers in vivo; and (3)  elucidate the molecular basis of flat and 
polypoid colorectal tumor morphology determination.   
 Although progress has been made in the treatment of CRC, prevention and early 
detection remains key in battling this disease.  There is a general consensus that flat CRCs 
are more often missed by current screening methods compared to their polypoid counterparts 
and that flat cancers also present significant risk of progression to malignant disease 
(Soetikno et al. 2006; Speake et al. 2007).  Elucidating the molecular signaling components 
that contribute to the formation of flat CRC’s may provide us with novel tumor-specific 
markers that may ultimately lead to advancements in detection and treatment of this form of 
CRC. 
 
 80 
 Microarray clustering and batch effect correction.  Consistent with our data 
indicating that flat and polypoid CRCs have similar mutational sprectra and stromal content, 
our microarray-based gene expression analysis confirmed that these tumor morphologies are 
remarkably similar at the molecular level.  Considering our findings, we hypothesize that the 
mechanism underlying the determination of flat and polypoid CRC morphologies is inherent 
to the neighboring normal colon and not to the tumors themselves.    
Unsupervised cluster analysis indicates a strong strain-dependent influence on gene 
expression profiles.  Interestingly, we observed that all tumors clustered together by strain 
irrespective of morphology while normal colon samples did not.  This result was surprising 
as one would expect a strain-dependent effect on gene expression to also effect normal colon 
tissues.  While it is not clear why this is the case, it is possible that certain strain-dependent 
changes in gene expression are more robust in tumor tissues than in the normal colon.  For 
example, during the tumor initiation and promotion process, tumor growth processes 
occurring at the transcriptional level may result in more distinct gene expression profiles than 
exist in the normal colon between KK/HIJ and I/LNJ mice.   
As described in chapter 3, flat and polypoid colorectal tumors did not cluster 
independently as we anticipated.  This could be due to an experimental batch effect as the 
result of preparation of RNA samples and performing array hybridization reactions under 
varying conditions.  For these studies, tissue samples were processed and hybridized at two 
different times using different batches of microarrays and reagents.  To determine if this is 
the case, additional experiments will need to be performed to test for potential batch effects 
and if necessary, these effects will be corrected using distance weighted discrimination 
(DWD) normalization.  However, even if a batch effect exists, it is unlikely that correcting it 
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will reveal any significant differences in gene expression profiles between flat and polypoid 
colorectal tumors.  The more plausible explanation for these results is that flat and polypoid 
colorectal tumors, while bearing an unmistakably unique morphology, are actually quite 
similar in nature and that an “extra” tumor or host-mediated mechanism is responsible for 
determining tumor morphology.  This is consistent with our previous observations that flat 
and polypoid CRCs have similar mutational spectra as well as similar levels of tumor-
associated stroma.  Additionally, one may also consider a potential sex-effect on the mixed-
clustering of samples.  Such an effect is unlikely in this case however as each microarray 
batch was comprised of samples obtained from approximately equal numbers of male and 
female mice.  Furthermore, SAM analysis performed on gene lists generated from males and 
females independently showed only a nominal number of genes that varied by sex.   
 
Alternative mechanisms for determination of flat and polypoid CRC’s.  In 
chapter 3 we described a hypothetical cytokine-mediated mechanism that could influence the 
determination of flat and polypoid development, however we should consider additional 
possibilities by which this process may occur.  The candidate gene lists presented in chapter 
3 contain genes encoding proteins with a variety of functions including extracellular matrix 
components, inflammatory-response as well as cell proliferation and adhesion.  With this, 
one could envision additional mechanisms that could account for the differential formation of 
flat and polypoid CRC’s.  
It is important to envision CRC progression as a three-dimensional process.  With this 
we may consider whether the growth pattern is the result of tumor being attracted toward its 
direction of growth or if structural differences in the composition of the normal colonic 
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mucosa could influence tumor growth patterns.  For example, it is possible that normal 
neighboring colon tissues lacking specific extracellular matrix components may be less 
confining to early tumor growth therefore allowing them to spread laterally.  Conversely, a 
more-dense matrix may provide a more confining environment thereby limiting lateral 
growth, forcing tumors to grow outward resulting a polypoid morphology.  This model could 
at least in part be tested by performing immunohistochemical analysis to identify 
extracellular matrix and cell adhesion proteins that are differentially expressed between the 
normal colon and each morphology.    
Alternatively, variability in expression of specific cell adhesion molecules is another 
possible mechanism that could influence the direction of tumor growth.  Similar to the 
example above, lower levels of key cell adhesion molecules in neighboring normal colon 
tissue could account for the tendency of some tumors to spread laterally while others in areas 
of more highly expressed cell adhesion molecules grow outward.   
While these ideas are purely speculative, they should be considered in the design of 
future experiments which will be required to elucidate the mechanism underlying the 
determination of CRC morphology.   
 
Correlation of strain-dependent flat tumor frequency with gene expression 
profiles.  Given our findings, we hypothesize that the mechanism controlling flat and 
polypoid colorectal cancer morphology is inherent to the normal colon and have shown that 
the frequency of flat and polypoid cancers occurs in a strain-dependent manner (12). 
Recently, we measured the frequencies of flat and polypoid adenomas in eight additional 
mouse strains including A/J, FVB/NJ, BTBR T+tf/J, SWR/J, C57L/J, SM/J, MOLF/Ei and 
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KK/HIJ X I/LNJ F2) (Fig 4.1).  We observed a broad range of frequencies of flat adenoma 
multiplicity ranging from 10% to 83%.  Microarray analysis of basal gene expression in 
normal colon tissues across all 10 mouse strains will be used to identify gene expression 
signatures which correlate with flat or polypoid tumor frequency.  The outcome of this type 
of analysis will allow us to determine whether strain-dependent gene expression signatures 
are determinants of tumor morphology, and if so, provide insights into specific genes and 
molecular pathways requiring further investigation.  Knowledge of specific genes and 
signaling pathways that influence tumor morphology may result in the identification of 
molecular markers that are associated with flat tumor development, potentially allowing 
clinicians to identify individuals with increased risk of developing flat lesions.  A Pearson 
correlation between tumor morphology frequency and basal gene expression will be 
performed using the quantitative analysis function of SAM.  Genes with an r2 value of  +/- 
0.7 or above will be considered significant.     
 
A potential role of gut flora in the determination of colorectal tumor 
morphology.  Although we hypothesize that the mechanism underlying the determination of 
flat and polypoid CRC morphologies is inherent to the normal host colon, it is possible that 
colorectal tumor morphogenesis may be influenced by bacteria residing within the gut.  In 
support of our hypothesis that morphology is controlled directly by the host, a second cohort 
of I/LNJ and KK/HIJ mice obtained several years after the first showed nearly identical 
frequencies of flat and polypoid tumors respectively suggesting that morphology is 
genetically determined and inherent to the host.   
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However, it is also possible that there exist strain-dependent effects on gut flora that 
influence the spectra of bacterial strains residing within the host.  This could result in 
differential colonization of bacterial flora between strains, which could ultimately influence 
tumor morphology although additional studies would be necessary to test this hypothesis. 
 
Mapping of flat cancer markers.  Currently, individuals are evaluated for the 
presence colonic neoplasms with no prior knowledge pertaining to a patient’s likelihood of 
developing flat cancer.  The identification of genetic or biochemical markers that identify 
individuals at increased risk of developing flat colorectal cancers may provide a valuable tool 
in early detection of these lesions.  With this knowledge, colonoscopists would know in 
advance which patients may benefit most from additional time spent during the procedure or 
from additional diagnostic procedures that may enhance visualization of flat lesions.   
In an effort to identify markers associated with predisposition for flat CRC 
development, a genetic mapping study will be performed using I/LNJ and KK/HIJ mice.  Our 
first aim will be to determine if flat colorectal tumor morphology is dominant or recessive to 
polypoid (Fig 4.2).  We will then perform full genome single nucleotide polymorphism 
(SNP)-association analysis to map genetic loci that are involved with the determination of 
colorectal tumor morphology.   
We will use AOM to induce colorectal tumors in F1 mice as previously described and 
determine their frequency of flat and polypoid tumors.  This will allow us to determine if flat 
colorectal tumor morphology is recessively/dominantly inherited.  A predominance of 
polypoid tumors would indicate that this morphology is dominant to flat and vice versa, 
while an equal mix would indicate that morphology is not inherited in a dominant/recessive 
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manner.  Reciprocal back-crosses of F1 mice to I/LNJ and KK/HIJ mice will be set up to 
generate N2 progeny (Fig 4.3).  F1 x F1 matings will also be performed to generate F2 mice 
for additional mapping studies if needed.  If we determine that either morphology is 
recessively inherited, we will use the N2 generation generated by back-crossing F1 mice to 
the strain bearing the recessive morphology in order to map genetic loci encoding genes 
responsible for that morphology.  If however we observe an equal frequency of flat and 
polypoid tumors in the F1 mice, the F2 mapping project will provide stronger statistical 
power allowing for phenotypes not displaying a recessive mode of inheritance.   
 
Translational research and future applications for mouse colonoscopy models.  
As part of current screening and intervention guidelines, snare polypectomy is used to 
remove suspicious lesions during colonoscopy.  However, it has been reported that up to 24% 
of polypectomies fail to completely remove all adenomatous tissues, allowing eventual 
progression to carcinoma (Hurlstone et al. 2007) and (Winawer et al. 1993).  This may in part 
be due to the fact that optical colonoscopy is the current standard for CRC screening.  Here, 
success relies upon the ability of the endoscopist to correctly identify all lesions present.  
This is complicated by the presence of flat and depressed lesions that are more difficult to 
observe due to their tendency to grow laterally rather than into the lumen.  Furthermore, it 
has been reported that certain areas of the colon and rectum, particularly the folds of the 
colon and the anal verge tend to mask the presence of more subtle lesions (Hurlstone et al. 
2007). Observations made in our model are consistent with those in humans as we also 
experienced difficulty in identifying lesions near the anal verge (Fig 4.4).  To date, some 
progress has been made with the use of dyes such as indigo carmine and methylene blue to 
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better visualize flat lesions during colonoscopy collectively termed chromoscopic 
colonoscopy although this approach has met with limited success (Tung et al. 2001; 
Hurlstone et al. 2007).  The dye which is injected into the colon through the side port of the 
colonoscope tends to pool in the folds and crevace’s of the tumor, providing contrast against 
the normal, mucosa (Fig 4.4) (Sato et al. 1999; Hurlstone et al. 2007).  Future colonoscopy 
visualization studies in mice should prove beneficial in that novel contrast or tumor 
enhancing reagents may be tested for efficacy and toxicity thereby eliminating potential risk 
incurred with the testing of unknown reagents in humans. 
 Currently, progress is underway to develop highly sensitive tumor-specific 
fluorescent markers to aid in the visualization of colonic neoplasms.  Alencar and coworkers 
have recently tested the use of “smart probes” in the imaging of colonic neoplasms in mice 
(Mahmood and Weissleder 2003).  These polymer-based probes are activated upon 
proteolytic cleavage by proteinases that are often up-regulated in cancers (Liaudet et al. 
1995; Keppler et al. 1996; Kim et al. 1998).  Several proteinase-specific probes have been 
tested including those sensitive to cleavage by cathepsin B, cathepsin D, cathepsin K, MMP-
2 and caspase 3 (Mahmood and Weissleder 2003).  In their study, cathepsin B sensitive 
probes were injected intravenously into mice.  The probes were activated specifically in 
adenomatous tumors in the colon by cathepsin B specific cleavage resulting in the emission 
of near-infrared fluorescence (NIRF) which is detected by a microcatheter inserted into the 
colon (Mahmood and Weissleder 2003).  While our study has not shown tumor-specific over-
expression of cathepsin B, we have found significant over-expression of cathepsin E in 
addition to a variety of other proteases by microarray analysis (Table 1).  This technology 
holds much promise in enhancing the detection of flat CRCs as the probes are designed as 
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substrates for specific proteases.  This should allow for an array of fluorescent probes to be 
developed for specific protease-over-expressing tumors.  
Tools such as these may not only provide the ability to more consistently detect subtle 
flat lesions but may also prove useful in intervention studies in mice.  Currently, in order for 
tumor regression to be observed, mice are sacrificed at periodic intervals leaving the 
possibility that important events are not observed.  While more recent studies have used 
colonoscopy to observe tumor regression (Amos-Landgraf et al. 2007), colonoscopic imaging 
may be enhanced by adapting it so smart probe technology, greatly improving the resolution 
by which drug-tumor interactions occur.  In addition to allowing investigators to observe 
shorter yet significant periods of tumor regression that may otherwise be missed, the addition 
of smart probes may greatly enhance the ability to detect smaller lesions that may otherwise 
be missed by conventional colonoscopy.  Additionally, in humans this technology may serve 
as a tool to detect extraneous neoplastic tissue not removed by snare polypectomy or to 
evaluate potentially positive margins after surgical resection.  
 Current work is ongoing to adapt smart probe technology to capsule endoscopy (CE) 
(Zhang, Morgan in press).  CE utilizes a pill-sized camera that is swallowed by the patient, 
which captures images of the stomach, small- and large-intestine during peristalsis which are 
transmitted to a receiver fastened to the patients abdomen (Gong et al. 2000; Iddan et al. 
2000).  Progress has been made to adapt the relatively non-invasive CE camera to detect 
NIRF emitted by GI tumors.  There would likely be great benefit in combining these 
technologies.  Unlike colonoscopy, CE is minimally invasive and requires no sedation.  This 
aspect would greatly benefit individuals that can not tolerate sedation.  Additionally, unlike 
lengthy video generated by conventional colonoscopy, the use of CE in combination with 
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smart probes could allow for easier transfer of information around the world so that more 
experienced endoscopists could be consulted on difficult cases such as those containing 
questionable flat lesions. 
 
Concluding Remarks 
 We have provided evidence here that flat and polypoid CRCs are distinct entities and 
that these morphologies are genetically determined.  However, it is clear that flat and 
polypoid CRCs are molecularly similar, suggesting that colorectal tumor morphogenesis is 
controlled by the normal host colon.   
 Further research is necessary to improve upon the frequency of flat colorectal tumors 
missed during routine screening.  It is our hope that identification of a genetic flat tumor 
marker will allow for the identification of individuals who may be at increased risk for 
developing these lesions.  While progress continues in our understanding of flat CRC 
etiology, significant work remains in identifying the mechanism responsible for their 
development. 
 
 
 
 
 
 
 
 89 
Figure 4.1.  Frequency of flat tumors varies by strain.  Mice were treated with 10mg/kg b.w. 
AOM for six months and upon sacrifice colorectal tumors were counted and scored as either 
flat or polypoid.  Number of mice counted indicated as (n). 
 
 
 
 
 
 
 
 
 
 
 
 90 
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Figure 4.2.  Potential outcomes in F1 colorectal tumor morphology.  A.  Tumor morphologies 
are predominantly flat and therefore flat is dominant to polypoid.   B.  Tumor morphologies 
are predominantly polypoid therefore polypoid is dominant to flat.  C.  Tumor morphologies 
are mixed therefore tumor morphology is not a dominant-/recessively inherited trait. 
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Figure 4.3.  Mating scheme to generate I/LNJ (I) x KK/HIJ (K) F2 and N2 mice.  A.  I/LNJ 
mice were mated with KK/HIJ mice to generate IK F1 progeny.  IK F1 siblings were then 
mated to produce IK F2 progeny.  B.  IK F1 mice were backcrossed to KK/HIJ or I/LNJ mice 
to generate IKI and IKK N2 progeny. 
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Figure 4.4.  The anal verge obscures detection of flat tumors.  A.  Colonoscopic view of a 
small methylene blue stained flat tumor with central depression (red arrowhead) near the anal 
verge with full inflation.  B.  Same tumor shown in A. (red arrowhead) is obscured by muscle 
bulges of the anus (white arrowheads) as the colonoscope is removed and inflation is lost. 
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Table 4.1.  List of proteases over-expressed in AOM-induced 
colorectal tumors. 
Common name symbol    
Cathepsin E     
matrix metalloproteinase 7 Mmp7    
matrix metalloproteinase 9 Mmp9    
matrix metalloproteinase 10 Mmp10    
matrix metalloproteinase 13 Mmp13    
matrix metalloproteinase 14 Mmp14    
protease serine 11 neurotrypsin Prss11    
protease serine 12 neurotrypsin Prss12    
mast cell protease 1 Mcpt1    
mast cell protease 4 Mcpt4    
mast cell protease 5 Mcpt5    
SAM was performed to identify genes that were differentially expressed by 2-
fold or greater with a false discovery rate of 5% or less.  
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